Latest Articles

Publication Date
Uterine intravascular adenomyomatosis: Clinicopathological features and literature review of a rare entity.

Intravascular adenomyomatosis (IA), characterised by endometrial-type glands or stroma embedded within smooth muscle tissue inside myometrial vessels, is a rare variant within the spectrum of uterine intravenous leiomyomatosis (IVL).

Published: May 6, 2026, midnight
Managing Progression After Immunotherapy in Endometrial Cancer - OncLive

Managing Progression After Immunotherapy in Endometrial Cancer OncLive

Published: May 5, 2026, 12:07 p.m.
New Endometrial Targets Beyond HER2 - OncLive

New Endometrial Targets Beyond HER2 OncLive

Published: May 5, 2026, 12:06 p.m.
Differential Antioxidant Capacities of Human Endometriotic and Endometrial Cell Models Under H2O2 Exposure.

Endometriosis is associated with oxidative stress and debilitating symptoms, yet its pathophysiology remains incompletely understood, and current treatments are still limited. In this study, oxidative stress responses were compared in …

Published: May 5, 2026, midnight
Endometriosis Uncovered: From Chronic Inflammation to Reproductive Dysfunction and Impaired ART Outcomes.

Background and Objectives: Endometriosis is a chronic, estrogen-dependent disorder characterized by the presence of functional endometrial tissue, comprising both glandular and stromal components, located outside the uterine cavity, affecting approximately …

Published: May 5, 2026, midnight
Navigating Institutional Barriers: Inventory Management and EHR Pathways in Endometrial Cancer - Pharmacy Times

Navigating Institutional Barriers: Inventory Management and EHR Pathways in Endometrial Cancer Pharmacy Times

Published: May 4, 2026, 12:43 p.m.
Therapeutic Sequencing and NCCN Guidelines in Endometrial Cancer - Pharmacy Times

Therapeutic Sequencing and NCCN Guidelines in Endometrial Cancer Pharmacy Times

Published: May 4, 2026, 12:09 p.m.
Adenomyosis Independently Increases Risk for Endometrial Proliferative Disorders - Oncology Nurse Advisor

Adenomyosis Independently Increases Risk for Endometrial Proliferative Disorders Oncology Nurse Advisor

Published: May 4, 2026, 4 a.m.
Metabolic reprogramming in endometriosis: mechanisms and therapeutic prospects.

Endometriosis (EMS) is an estrogen-dependent chronic inflammatory disorder for which metabolic reprogramming has emerged as a central pathological feature. Driven by genetic, epigenetic, and microenvironmental stressors, ectopic endometrial cells undergo …

Published: May 3, 2026, midnight
In-Depth Examination of Segments, Industry Trends, and Key Competitors in the Endometrial Cancer Treatment Market - openPR.com

In-Depth Examination of Segments, Industry Trends, and Key Competitors in the Endometrial Cancer Treatment Market openPR.com

Published: May 1, 2026, 1:51 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!